UT Southwestern Scientists Discover Leptin can Also Aid Type 1 Diabetics 26 August 2008 Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by the scientists.
Bayer and Onyx Begin Enrollment in Storm Trial Studying Nexavar as Adjuvant Therapy for Patients with Liver Cancer 26 August 2008 The Phase 3 study is evaluating Nexavar® tablets as adjuvant treatment for patients with hepatocellular carcinoma.
Researchers uncover molecule that keeps pathogens like salmonella in check 26 August 2008 Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick.
Galapagos acquires structure-based drug discovery from Sareum 26 August 2008 Galapagos NV and Sareum Holdings plc announce today that Galapagos has acquired Sareum's assets in drug discovery services. These assets will position Galapagos' service division BioFocus DPI strongly in the growing field of structure-based drug discovery.
Novosom AG acquires exclusive license from Isis Pharmaceuticals, Inc. for CD40-targeted antisense inhibitors 26 August 2008 Novosom AG today announced that it has acquired an exclusive, worldwide license from Isis Pharmaceuticals to access certain antisense inhibitors targeting CD40 mRNA for a number of indications.
Neurologix Initiates Recruitment for Phase ll Parkinson’s Disease Trial 25 August 2008 The trial will evaluate the safety and efficacy of a novel non-dopaminergic approach for reestablishing motor function in Parkinson’s patients.
FDA Approves Nplate™ for Long-Term Treatment of Adult Chronic ITP 25 August 2008 Amgen to launch Nplate™ NEXUS program to provide treatment access and patient support programs.
Biogen Idec Initiates Phase III Clinical Trial for ADENTRI® 25 August 2008 The trial will access the efficacy of ADENTRI in acute decompensated heart failure patients with renal insufficiency.